GARDIMAN, MARINA PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 3.013
AS - Asia 991
EU - Europa 543
SA - Sud America 235
AF - Africa 113
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.913
Nazione #
US - Stati Uniti d'America 2.944
SG - Singapore 312
CN - Cina 251
BR - Brasile 184
VN - Vietnam 138
HK - Hong Kong 118
IT - Italia 103
DE - Germania 99
FI - Finlandia 43
KR - Corea 38
FR - Francia 37
PL - Polonia 35
GB - Regno Unito 28
RU - Federazione Russa 27
SE - Svezia 26
IN - India 20
NL - Olanda 18
CA - Canada 16
AT - Austria 13
CI - Costa d'Avorio 13
AR - Argentina 11
IE - Irlanda 11
ES - Italia 9
IQ - Iraq 9
TR - Turchia 9
UA - Ucraina 9
CZ - Repubblica Ceca 8
JP - Giappone 8
PE - Perù 8
BD - Bangladesh 7
IR - Iran 7
MX - Messico 7
PY - Paraguay 7
AL - Albania 6
EC - Ecuador 6
GH - Ghana 6
GR - Grecia 6
KE - Kenya 6
MA - Marocco 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AM - Armenia 5
BG - Bulgaria 5
EG - Egitto 5
LV - Lettonia 5
MR - Mauritania 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
UY - Uruguay 5
ZA - Sudafrica 5
AF - Afghanistan, Repubblica islamica di 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BE - Belgio 4
BY - Bielorussia 4
BZ - Belize 4
CM - Camerun 4
CU - Cuba 4
DZ - Algeria 4
GT - Guatemala 4
ID - Indonesia 4
IL - Israele 4
ME - Montenegro 4
NA - Namibia 4
PK - Pakistan 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
TZ - Tanzania 4
VE - Venezuela 4
AD - Andorra 3
AU - Australia 3
BO - Bolivia 3
BW - Botswana 3
CD - Congo 3
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
CW - ???statistics.table.value.countryCode.CW??? 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KG - Kirghizistan 3
LB - Libano 3
LY - Libia 3
MG - Madagascar 3
MY - Malesia 3
NI - Nicaragua 3
PR - Porto Rico 3
RE - Reunion 3
SN - Senegal 3
UG - Uganda 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
YT - Mayotte 3
AO - Angola 2
BJ - Benin 2
Totale 4.838
Città #
Fairfield 468
Ashburn 382
Chandler 282
Woodbridge 256
Singapore 185
Cambridge 181
Seattle 177
Houston 171
Ann Arbor 149
Wilmington 143
Hong Kong 115
Dong Ket 109
Beijing 77
Santa Clara 60
Boardman 47
San Diego 46
Princeton 39
Seoul 36
Hefei 35
Medford 35
Padova 34
Des Moines 30
Munich 29
Bytom 26
Helsinki 25
Nanjing 15
New York 14
Abidjan 13
Los Angeles 13
Jacksonville 12
Nuremberg 12
Chicago 11
Frankfurt am Main 11
Ho Chi Minh City 11
Jinan 11
São Paulo 11
Washington 11
Roxbury 10
Turku 10
Hanoi 9
Shenyang 9
Dublin 8
Falkenstein 8
Campinas 7
Salt Lake City 7
Council Bluffs 6
Düsseldorf 6
Guangzhou 6
Kilburn 6
Lima 6
Milan 6
Nanchang 6
Rio de Janeiro 6
Vienna 6
Athens 5
Hebei 5
Jiaxing 5
London 5
Montreal 5
Moscow 5
Nairobi 5
Nouakchott 5
Prague 5
San Francisco 5
Zhengzhou 5
Accra 4
Amsterdam 4
Baku 4
Brooklyn 4
Dallas 4
Douala 4
Guatemala City 4
Havana 4
Johannesburg 4
Manassas 4
Mexico City 4
Ningbo 4
Phoenix 4
Podgorica 4
Riga 4
Rome 4
Shanghai 4
Tampa 4
Villafranca Padovana 4
Warsaw 4
Yerevan 4
Andorra la Vella 3
Antananarivo 3
Auckland 3
Baghdad 3
Bari 3
Belo Horizonte 3
Bishkek 3
Brest 3
Brussels 3
Buffalo 3
Casablanca 3
Changsha 3
Charlotte 3
Curitiba 3
Totale 3.585
Nome #
A 10-year history of secondary hypertension: A challenging case of renin-secreting juxtaglomerular cell tumor 266
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 226
Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma 213
Intra-operative 5-aminolevulinic acid (ALA)-induced fluorescence of medulloblastoma: Phenotypic variability and CD133+ expression according to different fluorescence patterns 179
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model 178
Early recognition of aggressive pituitary adenomas: a single-centre experience 170
Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status 166
Does 1.5 T mpMRI play a definite role in detection of clinically significant prostate cancer? Findings from a prospective study comparing blind 24-core saturation and targeted biopsies with a novel data remodeling model 159
[Positive surgical margins after radical prostatectomy] 156
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours. 153
Novel insights on testicular volume and testosterone replacement therapy in Klinefelter patients undergoing testicular sperm extraction. A retrospective clinical study 152
Anaplastic Astrocytoma: State of the art and future directions 150
Functional VEGF and VEGF receptors are expressed in human medulloblastomas 147
Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin 144
A 14-year-old girl with multiple tumors. 141
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases 141
Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy. 140
Alström syndrome is associated with short stature and reduced GH reserve 135
Mismatch-repair protein expression in high-grade gliomas: A large retrospective multicenter study 130
PET-MRI crucial role in the diagnostic work-up of pan-medullary astrocytoma 129
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 127
Study of diagnostic accuracy of Fagan's two-step nomogram in increasing the value of predictive tools for prostate cancer: application of specific spatial distribution of positive/negative bioptic cores to predict extracapsular extension 124
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets 119
Predicting late recurrence in surgically-treated patients with Cushing's disease. 117
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 117
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab 116
Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma 112
A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas 112
Silent gonadotroph pituitary neuroendocrine tumor in a patient with tuberous sclerosis complex: evaluation of a possible molecular link 98
A clinico-pathological risk score for prediction of recurrence in patients with atypical meningioma 91
An Overview of Intracranial Ependymomas in Adults 90
Is "extreme" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure? 90
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 83
Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up. 82
Phosphorylated acetyl-coa carboxylase is associated with clinical benefit with regorafenib in relapsed glioblastoma: REGOMA trial biomarker analysis 74
Aggressive non-Hodgkin's lymphoma mimicking unilateral transitional cell carcinoma of renal pelvis. The risk of making a diagnostic mistake 54
Recurrent nephrogenic adenoma in bladder diverticulum: Case report and literature review 50
Leydig cell tumor or adrenal rest tumor of the testes? A case of uncertain diagnosis 41
Totale 4.972
Categoria #
all - tutte 18.390
article - articoli 17.927
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021586 0 0 46 42 19 31 41 57 73 82 66 129
2021/2022553 21 56 67 29 42 27 55 48 24 14 53 117
2022/2023455 81 72 9 82 60 53 0 23 47 5 16 7
2023/2024292 5 45 38 16 43 61 21 7 6 6 21 23
2024/20251.112 7 67 59 42 112 45 35 93 108 93 201 250
2025/2026765 235 360 170 0 0 0 0 0 0 0 0 0
Totale 4.972